Specializing in innovation and development within the pharmaceutical intermediates sector, the company has achieved significant success in the R&D and industrial production of synthetic processes for API intermediates represented by semaglutide and tirzepatide. It has also made remarkable progress in chiral amino acid process R&D, particularly in the industrialization of penicillamine. Additionally, the company offers full-process services for customized products, including R&D, production, and sales.
Facilities & Capabilities
Equipped with advanced laboratories, modern analytical equipment, multi-functional kilogram-scale labs, and pilot production workshops, the company serves global clien...
